Comments on: Second-Line Tislelizumab Prolongs OS in Advanced Esophageal Squamous Cell Carcinoma https://www.oncologynurseadvisor.com/home/cancer-types/gastrointestinal-cancer/esophageal-squamous-cell-carcinoma-tislelizumab-second-line-prolongs-survival/ Fri, 13 Oct 2023 20:51:39 +0000 hourly 1 https://wordpress.org/?v=6.4.3